{
  "pmcid": "6855316",
  "sha256": "e33cf0f9308b42bfb958922a46a4295ad32409aa90afeb2834e29fa95b709da1",
  "timestamp_utc": "2025-11-10T00:03:19.906303+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.861085972850681,
    "reading_ease": 35.903031674208165,
    "word_count": 247
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Tritube vs. Microlaryngeal Tube in Laryngeal Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly allocated to either the Tritube-FCV group or the MLT-VCV group."
      },
      "Participants": {
        "score": 2,
        "evidence": "55 patients over 18 years were assessed, with 40 included in the analysis. Eligibility criteria included elective laryngeal surgery, excluding those with ASA status >III, planned laser surgery, or COPD >GOLD II."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly allocated to either the Tritube-FCV group or the MLT-VCV group."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed whether a Tritube with flow-controlled ventilation (FCV) improves laryngeal visibility and surgical conditions compared to a conventional microlaryngeal tube (MLT) with volume-controlled ventilation (VCV) during elective laryngeal surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the concealment of laryngeal structures, measured immediately post-intubation."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated in blocks of 10, with allocation concealed in closed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not possible due to visible differences in tubes."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From October 2017 to May 2018, 20 patients were randomised to each group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was per-protocol."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The Tritube group showed significantly less laryngeal concealment (7% [6 to 9]) compared to the MLT group (22% [18 to 27], p < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: DRKS00013097."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}